JDP Therapeutics, Inc.

Quick facts

Phase 3 pipeline

• JDP-205 Injection · Oncology
  JDP-205 Injection is a monoclonal antibody targeting the PD-1 receptor.
• Test Drug (JDP-205) · Cardiovascular
  Test Drug (JDP-205) is a small molecule that targets a specific molecular pathway.

Phase 1 pipeline

• Control: Zyrtec
• JDP-205 IM
• JDP-205 IV high dose
• JDP-205 IV low dose

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• JDP Therapeutics, Inc. portfolio CI brief
• JDP Therapeutics, Inc. pipeline updates RSS